Search

Search Results

7 results found. Results per page: [ 20 ] [ 40 ] [ 60 ] [ 80 ] [ 100 ] [ 200 ] [ 300 ]

Sort by: [ Publication Date ] [ Score ]

Direction: [ Desc ] [ Asc ]

Year of publication: [ 2026 ] [ 2025 ] [ 2024 ] [ 2023 ] [ 2022 ] [ 2021 ] [ 2020 ] [ 2019 ] [ 2018 ] [ 2017 ] [ 2016 ] [ 2015 ] [ 2014 ] [ 2013 ] [ 2012 ] [ 2011 ] [ 2010 ] [ 2009 ] [ Any ]

• EditorialVolume 8, Issue 8pp 1574-1575

  HER2-positive feline mammary carcinoma

  Relevance score: 0.00

  Cláudia Marques, Jorge Correia, Fernando Ferreira

  Keywords: feline mammary carcinoma, HER2-positive subtype, sHER2, cancer model

  Published in Aging on August 11, 2016

• Research PaperVolume 11, Issue 22pp 10052-10060

  Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment

  Relevance score: 0.00

  Chen Xu, Yalan Liu, Dongxian Jiang, Xiaowen Ge, Jie Huang, Jieakesu Su, Xue Zhang, Shaohua Lu, Yuan Ji, Jun Hou, Tianshu Liu, Yingyong Hou

  Keywords: gastric cancer, HER2, heterogeneity, trastuzumab, dual block

  Published in Aging on November 17, 2019

  Show abstract
• Research PaperVolume 9, Issue 2pp 508-523

  Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor

  Relevance score: 0.00

  Cristina Andreani, Caterina Bartolacci, Kathleen Wijnant, Rita Crinelli, Marzia Bianchi, Mauro Magnani, Albana Hysi, Manuela Iezzi, Augusto Amici, Cristina Marchini

  Keywords: breast cancer, Δ16HER2 mice, resveratrol, estrogen receptor, proteasome

  Published in Aging on February 26, 2017

  Show abstract
• Research PaperVolume 15, Issue 24pp 15473-15488

  Efficacy and safety analysis of a HER2-targeting antibody-drug conjugate combined with immune checkpoint inhibitors in solid tumors: a real-world study

  Relevance score: 0.00

  Yi-Xin Zhou, Jia-Ling Wang, Xiao-Li Mu, Ya-Juan Zhu, Ye Chen, Ji-Yan Liu

  Keywords: Disitamab Vedotin, immune checkpoint inhibitors, HER2, solid tumors

  Published in Aging on December 22, 2023

  Show abstract
• Research PaperVolume 12, Issue 4pp 3249-3265

  The IL1β-HER2-CLDN18/CLDN4 axis mediates lung barrier damage in ARDS

  Relevance score: 0.00

  Xinhua Ma, Xin Yu, Qi Zhou

  Keywords: acute respiratory distress syndrome, lung barrier injury, IL-1β, HER2, claudin18

  Published in Aging on February 15, 2020

  Show abstract
• EditorialVolume 14, Issue 14pp 5612-5613

  Metformin and breast cancer: an opportunity for pharmacogenetics

  Relevance score: 0.00

  Elisabet Cuyàs, Begoña Martin-Castillo, Javier A. Menendez

  Keywords: metformin, breast cancer, single-nucleotide variant, type 2 diabetes, HER2

  Published in Aging on July 18, 2022

• EditorialVolume 9, Issue 12pp 2457-2458

  CXCL12-CXCR4 axis in feline mammary carcinoma

  Relevance score: 0.00

  Fernando Ferreira

  Keywords: feline mammary carcinoma, CXCL12, CXCR4, target therapy, HER2-positive subtype, cancer model

  Published in Aging on December 11, 2017